Get the Stockscreener App
3.20
21.67%
0.57
Immunoprecise Antibodies Ltd stock is traded at $3.20, with a volume of 2.99M.
It is up +21.67% in the last 24 hours and up +88.24% over the past month.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.
See More
Previous Close:
$2.63
Open:
$2.65
24h Volume:
2.99M
Relative Volume:
1.18
Market Cap:
$147.69M
Revenue:
$16.77M
Net Income/Loss:
$-11.87M
P/E Ratio:
-6.7482
EPS:
-0.4742
Net Cash Flow:
$-5.90M
1W Performance:
+60.00%
1M Performance:
+88.24%
6M Performance:
+728.80%
1Y Performance:
+283.23%
1-Day Range:
$2.6401
$3.21
1-Week Range:
$2.0016
$3.21
52-Week Range:
$0.30
$3.21
Immunoprecise Antibodies Ltd Stock (IPA) Company Profile
Name
Immunoprecise Antibodies Ltd
Sector
Industry
Phone
-
Address
-
Compare IPA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IPA
Immunoprecise Antibodies Ltd
|
3.20 | 124.62M | 16.77M | -11.87M | -5.90M | -0.4742 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-22 | Initiated | H.C. Wainwright | Buy |
| Oct-25-21 | Initiated | The Benchmark Company | Buy |
Immunoprecise Antibodies Ltd Stock (IPA) Latest News
ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation - orrick.com
Technical Charts Suggest Momentum Shift in ImmunoPrecise Antibodies Ltd.Market Risk Report & Free High Return Stock Watch Alerts - thegnnews.com
ImmunoPrecise Antibodies Ltd. Reaches Critical Trendline Support2025 Bull vs Bear & Fast Gain Stock Trading Tips - newsyoung.net
Visual trend scoring systems applied to ImmunoPrecise Antibodies Ltd.Insider Buying & Reliable Breakout Forecasts - Newser
How to interpret RSI for ImmunoPrecise Antibodies Ltd. stockCPI Data & Weekly Breakout Watchlists - Newser
What to expect from ImmunoPrecise Antibodies Ltd. in the next 30 daysCPI Data & Proven Capital Preservation Methods - Newser
News impact scoring models applied to ImmunoPrecise Antibodies Ltd.July 2025 Analyst Calls & Daily Oversold Stock Bounce Ideas - Newser
Is ImmunoPrecise Antibodies Ltd. stock bottoming outWatch List & Daily Chart Pattern Signals - Newser
Published on: 2025-08-19 05:59:43 - Newser
Identifying reversal signals in ImmunoPrecise Antibodies Ltd.2025 Geopolitical Influence & Weekly High Momentum Picks - Newser
What machine learning models say about ImmunoPrecise Antibodies Ltd.July 2025 Action & Long-Term Growth Stock Strategies - Newser
Is ImmunoPrecise Antibodies Ltd. stock ready for a breakoutQuarterly Portfolio Review & Safe Swing Trade Setups - Newser
ImmunoPrecise Antibodies Ltd. Recovers — But Is It SustainableQuarterly Earnings Report & Weekly Chart Analysis and Guides - 선데이타임즈
Applying Wyckoff theory to ImmunoPrecise Antibodies Ltd. stockWeekly Earnings Recap & High Win Rate Trade Alerts - Newser
Strategies to average down on ImmunoPrecise Antibodies Ltd.Earnings Risk Summary & Smart Swing Trading Alerts - Newser
Is it too late to sell ImmunoPrecise Antibodies Ltd.2025 Year in Review & Low Drawdown Momentum Ideas - Newser
Published on: 2025-08-17 14:30:11 - Newser
Why ImmunoPrecise Antibodies Ltd. stock attracts strong analyst attentionWeekly Trend Report & Fast Entry High Yield Tips - Newser
Analyzing recovery setups for ImmunoPrecise Antibodies Ltd. investorsLong Setup & Safe Capital Growth Stock Tips - Newser
What technical models suggest about ImmunoPrecise Antibodies Ltd.’s comebackIPO Watch & Weekly Chart Analysis and Trade Guides - Newser
Historical volatility pattern of ImmunoPrecise Antibodies Ltd. visualizedJuly 2025 Highlights & Real-Time Volume Analysis - Newser
Visual analytics tools that track ImmunoPrecise Antibodies Ltd. performanceJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - Newser
Is ImmunoPrecise Antibodies Ltd. forming a reversal pattern2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
Risk vs reward if holding onto ImmunoPrecise Antibodies Ltd.Trade Entry Report & Step-by-Step Swing Trade Plans - Newser
Published on: 2025-08-15 09:47:46 - 선데이타임즈
ImmunoPrecise Antibodies Ltd. Added to Custom Quant Screener TodayDip Buying & Weekly Momentum Picks - beatles.ru
ImmunoPrecise Antibodies (OTCMKTS:IPATF) Trading 8.1% Higher – Here’s Why - Defense World
Is ImmunoPrecise Antibodies Ltd. stock a good hedge against inflationFree Technical Entry Strategy for Beginners - Newser
ImmunoPrecise Antibodies Maintains Buy Rating on Strong Canadian Growth and Strategic Divestment - AInvest
AVS Bio Expands Capabilities in Antibody Discovery and Protein Production with Acquisition of ImmunoPrecise Antibodies Europe - AInvest
AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities with Acquisition of ImmunoPrecise Antibodies Europe from ImmunoPrecise Antibodies Ltd. - MarketScreener
Immunic, Inc. shares fall 1.43% after-hours as ImmunoPrecise Antibodies Ltd. reports earnings miss and auditor raises 'going concern' doubt. - AInvest
Angi (ANGI) Q2 Revenue Beats by 6% - AOL.com
Inmune Bio Inc. shares fall 1.09% after-hours as ImmunoPrecise Antibodies Ltd. reports earnings miss and auditor raises 'going concern' doubt. - AInvest
Sensei (SNSE) Q2 Loss Narrows 31% - AOL.com
Aurinia (AUPH) Q2 Revenue Jumps 22% - AOL.com
ImmunoPrecise Antibodies Divests Netherlands Facilities to AVS Bio - citybiz
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2025 Earnings Call Transcript - MSN
Beta Bionics (BBNX) Q2 Revenue Soars 54% - AOL.com
ImmunoPrecise Antibodies divests Netherlands facilities to AVS Bio - MSN
AVS Bio, an Arlington Capital Partners Portfolio Co. Acquires ImmunoPrecise Antibodies Europe - citybiz
AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities With Acquisition of ImmunoPrecise Antibodies Europe From ImmunoPrecise Antibodies Ltd. - Silicon Canals
ImmunoPrecise Antibodies Divests Dutch Subsidiary to Focus on AI Innovation - TipRanks
ImmunoPrecise Antibodies sells Netherlands subsidiary to AVS Bio for $12m - Investing.com Australia
TR | OpenAI4o Initiates ImmunoPrecise Antibodies(IPA.US) With Hold Rating, Announces Target Price $2 - 富途牛牛
Day One (DAWN) Q2 Revenue Jumps 313% - AOL.com
Prothena Q2 Revenue Drops 97% - AOL.com
ImmunoPrecise Antibodies (NASDAQ:IPA) Upgraded at Wall Street Zen - Defense World
Agilon Health (AGL) Q2 Revenue Falls 6% - AOL.com
ImmunoPrecise (IPA) Q4 2025 Earnings Transcript - AOL.com
ITRM Reports Results - AOL.com
Immunoprecise Antibodies Ltd Stock (IPA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):